134 related articles for article (PubMed ID: 2481871)
21. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Fu X; Tan L; Liu S; Li H; Chen L; Qin J; Wu M; Wang H
J Cancer Res Clin Oncol; 2004 Sep; 130(9):514-20. PubMed ID: 15221469
[TBL] [Abstract][Full Text] [Related]
22. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.
Christensen WN; Boitnott JK; Kuhajda FP
Mod Pathol; 1989 Jan; 2(1):8-12. PubMed ID: 2466290
[TBL] [Abstract][Full Text] [Related]
23. Epithelial antigens in carcinomas of the ovaries. Relation to histological classification.
Jørgensen A; Nielsen K
APMIS; 1994 Jul; 102(7):533-7. PubMed ID: 7522476
[TBL] [Abstract][Full Text] [Related]
24. Epithelial membrane antigen expression in cholangiocarcinoma. An useful immunohistochemical tool for differential diagnosis with hepatocarcinoma.
Bonetti F; Chilosi M; Pisa R; Novelli P; Zamboni G; Menestrina F
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):307-13. PubMed ID: 6314640
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study of lysozyme, alpha 1-anti-chymotrypsin, tissue polypeptide antigen, keratin and carcinoembryonic antigen in effusion sediments.
Permanetter W; Wiesinger H
Acta Cytol; 1987; 31(2):104-12. PubMed ID: 2435101
[TBL] [Abstract][Full Text] [Related]
26. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
[TBL] [Abstract][Full Text] [Related]
29. Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis.
Leandro G; Basso D; Fabris C; Zizzari S; Elba S; Del Favero G; Di Mario F; Meggiato T; Angonese C; Naccarato R
J Cancer Res Clin Oncol; 1989; 115(3):276-8. PubMed ID: 2473990
[TBL] [Abstract][Full Text] [Related]
30. Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1991 Mar; 63(3):386-9. PubMed ID: 1848439
[TBL] [Abstract][Full Text] [Related]
31. [A clinicopathological study of 108 consecutive primary hepatic malignancies in the University of Occupational and Environmental Health].
Haratake J; Horie A; Taoka Y; Okuno F; Takeda S; Sato H
Gan No Rinsho; 1987 Oct; 33(13):1689-93. PubMed ID: 2447304
[TBL] [Abstract][Full Text] [Related]
32. Tissue copper content in primary and metastatic liver cancers.
Haratake J; Horie A; Takeda S; Kobori K; Sato H; Tokudome S
Acta Pathol Jpn; 1987 Feb; 37(2):231-8. PubMed ID: 3037846
[TBL] [Abstract][Full Text] [Related]
33. Histologic markers in primary and metastatic tumors of the liver.
Ganjei P; Nadji M; Albores-Saavedra J; Morales AR
Cancer; 1988 Nov; 62(9):1994-8. PubMed ID: 2458825
[TBL] [Abstract][Full Text] [Related]
34. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
[TBL] [Abstract][Full Text] [Related]
35. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors.
Wick MR; Cooper PH; Swanson PE; Kaye VN; Sun TT
Arch Dermatol; 1990 Feb; 126(2):189-94. PubMed ID: 1689137
[TBL] [Abstract][Full Text] [Related]
36. Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies.
Pinkus GS; Etheridge CL; O'Connor EM
Am J Clin Pathol; 1986 Mar; 85(3):269-77. PubMed ID: 2428237
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type.
Fisher HP; Doppl W; Osborn M; Altmannsberger M
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(2):71-6. PubMed ID: 2467436
[TBL] [Abstract][Full Text] [Related]
38. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
39. An immunohistochemical study of sarcomatoid liver carcinomas.
Haratake J; Horie A
Cancer; 1991 Jul; 68(1):93-7. PubMed ID: 1710948
[TBL] [Abstract][Full Text] [Related]
40. The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma.
Kew MC; Berger EL
Cancer; 1986 Jul; 58(1):127-30. PubMed ID: 2423221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
